SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

|The Artificial Superintelligence (ASI) Alliance is the world’s largest open-source initiative dedicated to decentralized Artificial General Intelligence (AGI). Formed in April 2024, the ASI Alliance unites SingularityNET, Fetch.ai, and Ocean Protocol, with CUDOS joining as a network member shortly after. The ASI Alliance was established through a community-approved tokenomic merger—combining $AGIX, $FET, and $OCEAN into a single token: $FET. This unified token underpins a collaborative framework designed to scale open-source AI and stand as the largest open-sourced, independent entity in AI research and development. The Alliance is committed to accelerating the advancement of decentralized Artificial General Intelligence (AGI) and, ultimately, Artificial Superintelligence (ASI). It provides a robust, open-source innovation stack, empowering developers, enterprises, and researchers globally to build ethical, scalable, and groundbreaking AI solutions. This ensures that advanced intelligence remains a shared, accessible resource, fostering innovation beyond centralized systems and promoting a future where AI benefits all.

Fetch.ai

Fetch.ai is trending as investors actively accumulate the token, viewing it as a primary infrastructure play for decentralized AI agents amidst broader sector momentum. The community is heavily focused on potential breakout levels and long-term scaling, with many highlighting recent enterprise collaborations and the project's pivotal role in the Artificial Superintelligence Alliance.

Dogelon Mars

Dogelon Mars continues to trend on social platforms as the community maintains high engagement through persistent speculation on future utility and potential price catalysts. While some investors remain skeptical due to long-term performance, others are actively tracking market developments and comparing the project against broader meme coin trends in anticipation of a breakout.

Venture Global, Inc. engages in the provision of United States liquefied natural gas sourced from resource rich North American natural gas basins. It operates through the following segments: Calcasieu Project, Plaquemines Project, CP2 Project, and Sales and shipping. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Global is trending as investors weigh the stock's significant earnings growth and rising demand for U.S. LNG against persistent market volatility tied to Middle East tensions and recurring rumors of peace deals. The community remains focused on the company's long-term potential as a dominant exporter, with active discussions debating whether to treat the stock's fluctuations as a war-driven trading opportunity or a fundamental long-term hold.

C3.ai, Inc. engages in the provision of enterprise artificial intelligence software for digital transformation. It delivers the C3 AI suite for developing, deploying, and operating large-scale AI, predictive analytics, and Internet of Things applications in addition to a portfolio of turn-key AI applications. It operates through the following geographical segments: North America, Europe, The Middle East, and Africa, Asia Pacific, and Rest of World. The company was founded by Thomas M. Siebel, Patricia A. House and Stephen Maurice Ward, Jr. on January 8, 2009 and is headquartered in Redwood City, CA.

C3.ai Inc - Ordinary Shares - Class A

C3.ai Inc

C3.ai is currently generating significant community buzz as investors weigh its potential for a short squeeze against concerns over recent insider selling and weak financial performance. Market participants are actively debating the company's future, with many pointing to its critical government contracts and the potential for strategic mergers as key catalysts that could drive a reversal for this long-suffering stock.

Virgin Galactic Holdings, Inc. is an aerospace and space travel company, which engages in the provision of consumer space experience using reusable spaceflight systems. The firm is also involved in designing, developing, and manufacturing, ground and flight testing, spaceflight operation, and post-flight maintenance of spaceflight systems. The company was founded on May 5, 2017 and is headquartered in Tustin, CA.

Virgin Galactic Holdings Inc - Ordinary Shares - Class A

Virgin Galactic Holdings Inc

Virgin Galactic is experiencing high retail interest and heavy trading volume fueled by speculative anticipation of upcoming commercial operations and excitement surrounding a potential broader space-sector rally. The community remains deeply polarized, with some traders targeting short-squeeze opportunities while others express long-term skepticism regarding the company's financial health and business model.

Ferrari NV is a holding company, which engages in the design, engineering, production, and sale of luxury sports cars. The firm's models include the F12Berlinetta, 488GTB, 488 Spider, 458 Speciale, California T, the LaFerrari Hybrid, LaFerrari, and the FF four-wheel drive. It participates in car racing such as Formula One. The company was founded by Enzo Anselmo Ferrari in 1939 and is headquartered in Maranello, Italy.

Ferrari N.V.

Ferrari shares have faced significant downward pressure and intense community debate following a revised, more cautious long-term growth and electrification outlook, which left some investors concerned about the brand's competitive trajectory. While traders remain wary of the stock's recent volatility and technical breakdown, many long-term shareholders are highlighting Ferrari's high-margin business model, consistent share buyback activity, and robust order backlog as reasons to view the pullback as a buying opportunity.

Atlassian Corp. is a holding company, which engages in providing team collaboration and productivity software. Its products include Jira Software, Confluence, Jira Service Management, and Loom. The company was founded by Michael Cannon-Brookes and Scott Farquhar in October 2002 and is headquartered in San Francisco, CA.

Atlassian Corporation - Ordinary Shares - Class A

Atlassian Corporation Plc

Atlassian is experiencing intense market volatility and significant bearish sentiment following its removal from the Nasdaq-100, fueling community debates on whether the stock is a deep-value turnaround opportunity or facing structural obsolescence due to AI agents. Investors remain sharply divided, with bulls pointing to the continued enterprise reliance on Jira and Confluence as a resilient moat, while bears argue that agentic AI and shifting IT spending are permanently eroding the company's SaaS business model.

JetBlue Airways Corp. engages in the provision of air transportation services. Its brands include jetBlue, jetBlue Vacations, Paisly, and TrueBlue. It operates through the following geographic segments: Domestic and Canada, Caribbean and Latin America, and Atlantic. The company was founded by David Gary Neeleman in August 1998 and is headquartered in Long Island City, NY.

Jetblue Airways Corp

JetBlue is trending as investors react to reports that the airline is exploring potential merger or sale options, with the community actively speculating on the likelihood of a strategic acquisition by a larger carrier. While bullish sentiment is fueled by buyout rumors and recent operational expansion, concerns remain regarding the company's debt levels and the broader impact of rising fuel costs on the airline sector.

Litecoin is a decentralized, peer-to-peer digital currency designed to enable instant, near-zero cost payments to individuals and merchants worldwide. As an open-source global payment network that functions independently of central banks or intermediaries, its main value proposition lies in providing a scarce digital asset with a fixed maximum supply of 84 million tokens.  The network operates using a Proof of Work mechanism where computers solve complex puzzles to confirm transactions and secure the blockchain. It is distinguished by a block generation time of 2.5 minutes, which allows for faster transaction confirmations and a higher total throughput than earlier protocols. Key technical features include the Scrypt hashing algorithm, which promotes wider network participation, and MimbleWimble Extension Blocks, which improve user privacy by allowing transaction details to be hidden.  The LTC token is used for settling global payments, executing microtransactions through smaller units called litoshis, and diversifying digital portfolios with a highly liquid asset. New tokens are issued to miners as rewards for verifying blocks, though these rewards undergo a halving event approximately every four years to strictly control inflation. This process ensures the ledger maintains immutability, meaning records cannot be changed once they are saved to the global network.  Created by former Google engineer Charlie Lee, the project is supported by the Litecoin Foundation, a non-profit organization dedicated to ecosystem adoption. Unlike many venture-backed projects, it is maintained by a decentralized community of independent developers and a global network of miners. The project has seen recent institutional adoption, with entities like Lite Strategy and Luxxfolio Holdings adding significant amounts of LTC to their corporate treasuries as of late 2025.

Litecoin

Litecoin is trending as investors debate its role as "digital silver" and track potential breakout levels against Bitcoin while community excitement builds around the LitVM testnet development. Sentiment remains polarized between long-term holders emphasizing the coin's longevity and utility against critics who point to its underperformance and historical price ratios.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit Therapeutics is currently a focal point for the investment community as it advances its lead immunotherapy candidate, ivonescimab, toward a pivotal FDA decision in late 2026. Investors are closely monitoring upcoming clinical trial data and pipeline updates, while actively debating the stock's potential as a competitor in the oncology space despite recent market volatility and analyst ratings.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

S&P 500 Jumps For Ninth Week, Longest Since 2023 With DELL Leading Nasdaq To Record Highs, While Positive US-Iran Ceasefire Bets Aid Dow —  UMG, COIN, MNKD, ASTC, ASTS In Focus

Equity

President Donald Trump said he was ready to make a “final determination” on a preliminary agreement to extend the ceasefire.

MNKD Stock Jumps On Receiving FDA Approval For Afrezza To Treat Diabetes In Children 

U.S. Food and Drug Administration (FDA) has approved Afrezza Inhalation Powder for use in children and adolescents aged 6 and older living with type 1 and type 2 diabetes. 

MNKD Stock Eyes Best Month Since 2022 Ahead Of FDA Decision On Pediatric Diabetes Treatment

The FDA set a PDUFA action date for MannKind’s Afrezza inhaled insulin therapy for children and adolescents with diabetes.

UTHR Holds As Tyvaso Shows 33% Lower Worsening Risk In Rare Lung Scarring Disease

The $59B Quiet Shift Reshaping How Patients Access Care

The $59B Quiet Shift Reshaping How Patients Access Care The $59B Quiet Shift Reshaping How Patients Access Care PR Newswire VANCOUVER, BC, May 12, 2026 Issued on behalf of VentriPoint Diagnostics...

Compared to Estimates, MannKind (MNKD) Q1 Earnings: A Look at Key Metrics

The headline numbers for MannKind (MNKD) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

MannKind (MNKD) Q1 2026 Earnings Transcript

@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...

MannKind (MNKD) Reports Q1 Loss, Misses Revenue Estimates

MannKind (MNKD) delivered earnings and revenue surprises of -150.00% and -13.05%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

MannKind (NASDAQ:MNKD) Shares Gap Up - Should You Buy?

MannKind (NASDAQ:MNKD) Shares Gap Up - Should You Buy...

MNKD Stock Records Biggest Single-Day Gains In Over 5 Years, Breaches A Key Technical Milestone – What’s Driving This Rally?

MannKind is developing a dry powder inhalation version of a drug to treat pulmonary arterial hypertension.

MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Danbury, CT.

Mannkind Corp

Extremely Bullish Sentiment

The FDA recently approved inhaled insulin for children ages 6 and older, sparking intense debate on market adoption potential versus execution risks.

Investors are clamoring for a global pharma partnership to accelerate commercial reach and provide the resources needed for a successful drug relaunch.

Market attention is shifting toward the upcoming July 26th PDUFA decision regarding the inhalable autoinjector as a major value-driving event.

Bulls are aggressively betting on a sharp move higher as short sellers face pressure to cover following the latest positive clinical developments.

MNKD
Mannkind Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Compact View

Latest MNKD News

MNKDMannkind Corp